No headlines found.
Globe Newswire (Mon, 14-Sep 7:00 AM ET)
Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
Globe Newswire (Thu, 3-Sep 4:05 PM ET)
Globe Newswire (Tue, 21-Jul 7:00 AM ET)
Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Globe Newswire (Wed, 8-Jul 7:02 AM ET)
Pasithea Therapeutics Corp. - Warrant trades on the stock market under the symbol KTTAW.
As of October 7, 2026, KTTAW stock price was flat at $0.00 with million shares trading.
KTTAW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, KTTAW traded as high as $.12 and as low as $.00.
KTTAW has underperformed the market in the last year with a price return of -79.4% while the SPY ETF gained +16.9%. KTTAW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -60.0% and 0.0%, respectively, while the SPY returned +3.7% and +0.5%, respectively.
KTTAW support price is $.00 and resistance is $.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KTTAW shares will trade within this expected range on the day.
